Analysis of Contractile Function of Permeabilized Human Hypertrophic Cardiomyopathy Multicellular Heart Tissue

Background: Many forms of hypertrophic cardiomyopathy (HCM) show an increased myofilament Ca2+ sensitivity. This observation has been mainly made in HCM mouse models, myofilament systems, and cardiomyocytes. Studies of multicellular tissues from patients with different HCM-associated gene mutations...

Full description

Bibliographic Details
Main Authors: Nico Kresin, Sabrina Stücker, Elisabeth Krämer, Frederik Flenner, Giulia Mearini, Julia Münch, Monica Patten, Charles Redwood, Lucie Carrier, Felix W. Friedrich
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-03-01
Series:Frontiers in Physiology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fphys.2019.00239/full
id doaj-9afd9321f0244aeeaedb90d00b1f6ea0
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Nico Kresin
Nico Kresin
Sabrina Stücker
Sabrina Stücker
Elisabeth Krämer
Elisabeth Krämer
Frederik Flenner
Frederik Flenner
Giulia Mearini
Giulia Mearini
Julia Münch
Monica Patten
Charles Redwood
Lucie Carrier
Lucie Carrier
Felix W. Friedrich
Felix W. Friedrich
spellingShingle Nico Kresin
Nico Kresin
Sabrina Stücker
Sabrina Stücker
Elisabeth Krämer
Elisabeth Krämer
Frederik Flenner
Frederik Flenner
Giulia Mearini
Giulia Mearini
Julia Münch
Monica Patten
Charles Redwood
Lucie Carrier
Lucie Carrier
Felix W. Friedrich
Felix W. Friedrich
Analysis of Contractile Function of Permeabilized Human Hypertrophic Cardiomyopathy Multicellular Heart Tissue
Frontiers in Physiology
myofilament
Ca2+ sensitivity
hypertrophic cardiomyopathy
MYBPC3
epigallocatechin-3-gallate
NanoString nCounter
author_facet Nico Kresin
Nico Kresin
Sabrina Stücker
Sabrina Stücker
Elisabeth Krämer
Elisabeth Krämer
Frederik Flenner
Frederik Flenner
Giulia Mearini
Giulia Mearini
Julia Münch
Monica Patten
Charles Redwood
Lucie Carrier
Lucie Carrier
Felix W. Friedrich
Felix W. Friedrich
author_sort Nico Kresin
title Analysis of Contractile Function of Permeabilized Human Hypertrophic Cardiomyopathy Multicellular Heart Tissue
title_short Analysis of Contractile Function of Permeabilized Human Hypertrophic Cardiomyopathy Multicellular Heart Tissue
title_full Analysis of Contractile Function of Permeabilized Human Hypertrophic Cardiomyopathy Multicellular Heart Tissue
title_fullStr Analysis of Contractile Function of Permeabilized Human Hypertrophic Cardiomyopathy Multicellular Heart Tissue
title_full_unstemmed Analysis of Contractile Function of Permeabilized Human Hypertrophic Cardiomyopathy Multicellular Heart Tissue
title_sort analysis of contractile function of permeabilized human hypertrophic cardiomyopathy multicellular heart tissue
publisher Frontiers Media S.A.
series Frontiers in Physiology
issn 1664-042X
publishDate 2019-03-01
description Background: Many forms of hypertrophic cardiomyopathy (HCM) show an increased myofilament Ca2+ sensitivity. This observation has been mainly made in HCM mouse models, myofilament systems, and cardiomyocytes. Studies of multicellular tissues from patients with different HCM-associated gene mutations are scarce. We investigated Ca2+ sensitivity in multicellular cardiac muscle strips of HCM patients. We furthermore evaluated the use of epigallocatechin-3-gallate (EGCg), a Ca2+ desensitizer.Methods: After strip isolation from cardiac tissues with single (MYBPC3, MYH7) or double heterozygous mutations (MYBPC3/FLNC, MYH7/LAMP2, MYBPC3/MYH7) and permeabilization, we performed contractility measurements ±EGCg. We furthermore evaluated gene expression with a customized heart failure gene panel using the NanoString technology.Results: Fmax tended to be higher in HCM than in non-failing (NF) control strips and in single than in double heterozygous strips. Ca2+ sensitivity was higher by trend in most HCM vs. NF strips and by trend in tissues with double vs. single heterozygous mutations. EGCg desensitized myofilaments to Ca2+ in most of the strips and tended to induce a more pronounced shift in strips with truncating than missense or single than double heterozygous mutations. Gene expression analysis revealed lower ATP2A2, PPP1R1A, and FHL2 and higher NPPA, NPPB, COL1A1, CTGF, and POSTN marker levels in HCM than in NF tissues. NPPA, NPPB, ACTA1, CTGF, COL1A1, and POSTN levels were higher in tissues with missense than truncating mutations.Conclusion: We report an increased myofilament Ca2+ sensitivity in native multicellular cardiac HCM strips, which by trend was more pronounced in samples with double heterozygous mutations. EGCg could have differential effects depending on the underlying genetic status (single vs. double heterozygous) and type (missense vs. truncating).
topic myofilament
Ca2+ sensitivity
hypertrophic cardiomyopathy
MYBPC3
epigallocatechin-3-gallate
NanoString nCounter
url https://www.frontiersin.org/article/10.3389/fphys.2019.00239/full
work_keys_str_mv AT nicokresin analysisofcontractilefunctionofpermeabilizedhumanhypertrophiccardiomyopathymulticellularhearttissue
AT nicokresin analysisofcontractilefunctionofpermeabilizedhumanhypertrophiccardiomyopathymulticellularhearttissue
AT sabrinastucker analysisofcontractilefunctionofpermeabilizedhumanhypertrophiccardiomyopathymulticellularhearttissue
AT sabrinastucker analysisofcontractilefunctionofpermeabilizedhumanhypertrophiccardiomyopathymulticellularhearttissue
AT elisabethkramer analysisofcontractilefunctionofpermeabilizedhumanhypertrophiccardiomyopathymulticellularhearttissue
AT elisabethkramer analysisofcontractilefunctionofpermeabilizedhumanhypertrophiccardiomyopathymulticellularhearttissue
AT frederikflenner analysisofcontractilefunctionofpermeabilizedhumanhypertrophiccardiomyopathymulticellularhearttissue
AT frederikflenner analysisofcontractilefunctionofpermeabilizedhumanhypertrophiccardiomyopathymulticellularhearttissue
AT giuliamearini analysisofcontractilefunctionofpermeabilizedhumanhypertrophiccardiomyopathymulticellularhearttissue
AT giuliamearini analysisofcontractilefunctionofpermeabilizedhumanhypertrophiccardiomyopathymulticellularhearttissue
AT juliamunch analysisofcontractilefunctionofpermeabilizedhumanhypertrophiccardiomyopathymulticellularhearttissue
AT monicapatten analysisofcontractilefunctionofpermeabilizedhumanhypertrophiccardiomyopathymulticellularhearttissue
AT charlesredwood analysisofcontractilefunctionofpermeabilizedhumanhypertrophiccardiomyopathymulticellularhearttissue
AT luciecarrier analysisofcontractilefunctionofpermeabilizedhumanhypertrophiccardiomyopathymulticellularhearttissue
AT luciecarrier analysisofcontractilefunctionofpermeabilizedhumanhypertrophiccardiomyopathymulticellularhearttissue
AT felixwfriedrich analysisofcontractilefunctionofpermeabilizedhumanhypertrophiccardiomyopathymulticellularhearttissue
AT felixwfriedrich analysisofcontractilefunctionofpermeabilizedhumanhypertrophiccardiomyopathymulticellularhearttissue
_version_ 1724758558642274304
spelling doaj-9afd9321f0244aeeaedb90d00b1f6ea02020-11-25T02:46:23ZengFrontiers Media S.A.Frontiers in Physiology1664-042X2019-03-011010.3389/fphys.2019.00239417825Analysis of Contractile Function of Permeabilized Human Hypertrophic Cardiomyopathy Multicellular Heart TissueNico Kresin0Nico Kresin1Sabrina Stücker2Sabrina Stücker3Elisabeth Krämer4Elisabeth Krämer5Frederik Flenner6Frederik Flenner7Giulia Mearini8Giulia Mearini9Julia Münch10Monica Patten11Charles Redwood12Lucie Carrier13Lucie Carrier14Felix W. Friedrich15Felix W. Friedrich16Institute of Experimental Pharmacology and Toxicology, Cardiovascular Research Center, University Medical Center Hamburg-Eppendorf, Hamburg, GermanyDZHK (German Centre for Cardiovascular Research), Partner Site Hamburg/Kiel/Lübeck, Hamburg, GermanyInstitute of Experimental Pharmacology and Toxicology, Cardiovascular Research Center, University Medical Center Hamburg-Eppendorf, Hamburg, GermanyDZHK (German Centre for Cardiovascular Research), Partner Site Hamburg/Kiel/Lübeck, Hamburg, GermanyInstitute of Experimental Pharmacology and Toxicology, Cardiovascular Research Center, University Medical Center Hamburg-Eppendorf, Hamburg, GermanyDZHK (German Centre for Cardiovascular Research), Partner Site Hamburg/Kiel/Lübeck, Hamburg, GermanyInstitute of Experimental Pharmacology and Toxicology, Cardiovascular Research Center, University Medical Center Hamburg-Eppendorf, Hamburg, GermanyDZHK (German Centre for Cardiovascular Research), Partner Site Hamburg/Kiel/Lübeck, Hamburg, GermanyInstitute of Experimental Pharmacology and Toxicology, Cardiovascular Research Center, University Medical Center Hamburg-Eppendorf, Hamburg, GermanyDZHK (German Centre for Cardiovascular Research), Partner Site Hamburg/Kiel/Lübeck, Hamburg, GermanyUniversity Heart Center Hamburg, Hamburg, GermanyUniversity Heart Center Hamburg, Hamburg, GermanyRadcliffe Department of Medicine, University of Oxford, John Radcliffe Hospital, Oxford, United KingdomInstitute of Experimental Pharmacology and Toxicology, Cardiovascular Research Center, University Medical Center Hamburg-Eppendorf, Hamburg, GermanyDZHK (German Centre for Cardiovascular Research), Partner Site Hamburg/Kiel/Lübeck, Hamburg, GermanyInstitute of Experimental Pharmacology and Toxicology, Cardiovascular Research Center, University Medical Center Hamburg-Eppendorf, Hamburg, GermanyDZHK (German Centre for Cardiovascular Research), Partner Site Hamburg/Kiel/Lübeck, Hamburg, GermanyBackground: Many forms of hypertrophic cardiomyopathy (HCM) show an increased myofilament Ca2+ sensitivity. This observation has been mainly made in HCM mouse models, myofilament systems, and cardiomyocytes. Studies of multicellular tissues from patients with different HCM-associated gene mutations are scarce. We investigated Ca2+ sensitivity in multicellular cardiac muscle strips of HCM patients. We furthermore evaluated the use of epigallocatechin-3-gallate (EGCg), a Ca2+ desensitizer.Methods: After strip isolation from cardiac tissues with single (MYBPC3, MYH7) or double heterozygous mutations (MYBPC3/FLNC, MYH7/LAMP2, MYBPC3/MYH7) and permeabilization, we performed contractility measurements ±EGCg. We furthermore evaluated gene expression with a customized heart failure gene panel using the NanoString technology.Results: Fmax tended to be higher in HCM than in non-failing (NF) control strips and in single than in double heterozygous strips. Ca2+ sensitivity was higher by trend in most HCM vs. NF strips and by trend in tissues with double vs. single heterozygous mutations. EGCg desensitized myofilaments to Ca2+ in most of the strips and tended to induce a more pronounced shift in strips with truncating than missense or single than double heterozygous mutations. Gene expression analysis revealed lower ATP2A2, PPP1R1A, and FHL2 and higher NPPA, NPPB, COL1A1, CTGF, and POSTN marker levels in HCM than in NF tissues. NPPA, NPPB, ACTA1, CTGF, COL1A1, and POSTN levels were higher in tissues with missense than truncating mutations.Conclusion: We report an increased myofilament Ca2+ sensitivity in native multicellular cardiac HCM strips, which by trend was more pronounced in samples with double heterozygous mutations. EGCg could have differential effects depending on the underlying genetic status (single vs. double heterozygous) and type (missense vs. truncating).https://www.frontiersin.org/article/10.3389/fphys.2019.00239/fullmyofilamentCa2+ sensitivityhypertrophic cardiomyopathyMYBPC3epigallocatechin-3-gallateNanoString nCounter